Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary)
- Indications Osteoarthritis; Osteoporosis
- Focus Biomarker; Proof of concept; Therapeutic Use
- 20 Dec 2017 Planned End Date changed from 31 Dec 2019 to 31 Dec 2021.
- 20 Dec 2017 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2020.
- 29 Oct 2017 Status changed from not yet recruiting to recruiting.